Srivasavi Adhesive's margin squeeze is the price of its ambition
FY26 revenue grew 22% but PAT fell as ₹17 cr capex left new units running at 50% capacity. Management wants double-digit margins in FY27.
What's new
- FY26 revenue rose 22% YoY to ₹109.98 cr, but PAT fell to ₹6.01 cr from ₹6.80 cr.
- ₹17.14 cr capex in FY26 doubled the operating footprint to 200,000 sq ft across five units.
- First Defense PSU contract for mortar shell adhesive tapes and Indian Railways Part-1 approval secured.
Themes from the call
Demand
Entry into Defense, Railways, and EMS sectors signals a shift toward higher-barrier institutional contracts from a base of specialty tapes.
Margins
PAT declined despite revenue growth, reflecting ₹17 cr capex and underutilized new capacity (Units 3-4 at ~50% utilization).
Capacity
Unit 5 (polymer division, 6,000 tons/year) launches in FY27; Unit 6 targeting production in ~4 months. Path to ₹300+ cr revenue is at 85%+ utilization.
Guidance watch
- Management set a 1,000 crore long-term revenue vision and is targeting double-digit operating margins in FY27 as fixed-cost absorption improves.
Risk flags
- PAT fell to ₹6.01 cr in FY26 from ₹6.80 cr in FY25 despite 22% revenue growth, showing near-term margin pressure from capex.
- Defense expansion is characterized as a 'multi-quarter journey,' not a near-term revenue driver.
- Current capacity utilization at 50-70% implies significant ramp-up is needed before operating leverage hits.
Key quotes
-
"We crossed into genuinely high entry barrier sectors this year: our first Defense PSU contract for mortar shell adhesive tapes..."
— D.N. Anil Kumar, CMD -
"With 85% utilization of current infrastructure, path to Rs 300 plus crore revenue evident."
— Srivasavi management
The brief
Srivasavi Adhesive's FY26 is a story of investment ahead of returns. Revenue grew 22% to ₹109.98 cr, a record high, but profit fell to ₹6.01 cr from ₹6.80 cr. The reason is clear: the company spent ₹17.14 cr on capex, doubling its footprint to 200,000 sq ft and adding 77 employees. New units 3 and 4 are running at about half capacity.
The strategic wins are real. The Defense PSU contract for mortar shell adhesive tapes and Indian Railways Part-1 approval establish Srivasavi as an institutional supplier in sectors where credentials take years to earn. These are high-barrier, low-competition niches. Entry into the EMS sector, supplying electronics manufacturers who previously bought only from overseas, is another proof point for the R&D-led margin pyramid thesis.
The problem is timing. Management sees a path to ₹300+ cr revenue at 85% utilization and wants double-digit operating margins in FY27. That requires the new units to fill quickly. The polymer division (Unit 5) adds 6,000 tons of captive adhesive capacity in FY27, which should insulate margins from crude-linked input costs. But defense is a multi-quarter ramp, and the capex bill is still weighing on the P&L.
The market is being asked to fund a 1,000 crore vision built on three unproven institutional wins and a utilization ramp from 50% to 85%. The ₹160-175 cr annual order book projection per customer is aspirational until it converts to invoices. For now, Srivasavi is spending like a company that has already won the contracts it's still negotiating.
Srivasavi's margin pain is the cost of buying a seat at the institutional table. The bet is on credentials; the bill is due now.